Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | Distinguishing late-onset neutropenia from classical primary neutropenia

Carlo Dufour • 15 Apr 2024
EBMT 2024
General

Carlo Dufour, MD, G.Gaslini Research Children’s Hospital, Genoa, Italy, discusses late-onset and long-lasting neutropenia and how it differs from classical primary neutropenia. Late-onset neutropenia is characterized by a progressive reduction of absolute lymphocyte count and a T- and B-cell profile similar to autoimmune disorders. While likely acquired, it could also have a genetic basis. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Carlo Dufour

1:49
Guidelines on the diagnosis and management of neutropenia
Carlo Dufour • 15 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
4:55
New guidelines for the management of neutropenia & challenges in this space
Carlo Dufour • 23 Apr 2023
2:17
BMF diagnosis with NGS and gene panels
Carlo Dufour • 1 Sep 2020

Related Videos

2:15
Cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
Arjun Ghosh • 25 Apr 2024
1:09
Rethinking healthcare to improve affordability, sustainability, and patient outcomes
Richard Sullivan • 29 Apr 2024
3:10
The importance of nutrition in hematology and cancer care
Shireen Kassam • 24 Apr 2024
2:41
A trial investigating enoxaparin vs placebo as thromboprophylaxis in hospitalized older patients
Gregoire Le Gal • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals